Cargando…
Prognostic Value of MicroRNAs in Patients after Myocardial Infarction: A Substudy of PRAGUE-18
BACKGROUND: The evaluation of the long-term risk of major adverse cardiovascular events and cardiac death in patients after acute myocardial infarction (AMI) is an established clinical process. Laboratory markers may significantly help with the risk stratification of these patients. Our objective wa...
Autores principales: | Hromádka, M., Černá, V., Pešta, M., Kučerová, A., Jarkovský, J., Rajdl, D., Rokyta, R., Moťovská, Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875251/ https://www.ncbi.nlm.nih.gov/pubmed/31781298 http://dx.doi.org/10.1155/2019/2925019 |
Ejemplares similares
-
Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial
por: Hlinomaz, Ota, et al.
Publicado: (2021) -
The Effect of Diabetes on Prognosis Following Myocardial Infarction Treated with Primary Angioplasty and Potent Antiplatelet Therapy
por: Simek, Stanislav, et al.
Publicado: (2020) -
MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty
por: Hromadka, Milan, et al.
Publicado: (2021) -
Trends in outcomes of women with myocardial infarction undergoing primary angioplasty—Analysis of randomized trials
por: Motovska, Zuzana, et al.
Publicado: (2023) -
Myocardial Involvement Detected Using Cardiac Magnetic Resonance Imaging in Patients with Systemic Sclerosis: A Prospective Observational Study
por: Hromadka, Milan, et al.
Publicado: (2021)